

IN BRIEF: Silence Therapeutics Begins Dosing In SLN360 Phase 1 Trial


(Sharecast News) - Silence Therapeutics has started dosing subjects in the 'APOLLO' phase 1 clinical study of its wholly-owned lead product candidate ...


Silence Therapeutics Raises USD45 Million In Private Share Placing


(Sharecast News) - Novel therapeutics developer Silence Therapeutics announced an oversubscribed private placement of 2,022,218 American depositary sh...


UK EXECUTIVE CHANGE SUMMARY: Martin Gilbert Joins River & Mercantile


(Sharecast News) - Drug discovery outfit Silence Therapeutics has named Craig Tooman as its new chief financial officer.


UK DIRECTOR DEALINGS SUMMARY: Tesco's Simon Patterson Buys Shares


e-Therapeutics Names New Chief Executive; Plans To Ramp Up Research